Jefferson, Ohio State team find gene signature profile for metastasisJune 02, 2008A common signature of tiny, specific pieces of non-coding genetic material known as microRNAs (miRNAs) may be directly involved in the spread of cancer to other parts of the body. Researchers at the Kimmel Cancer Center at Jefferson in Philadelphia and Ohio State University Medical Center in Columbus have identified such a signature, made up mostly of overexpressed miRNAs. The findings, reported at the annual meeting of the American Society of Clinical Oncology in Chicago, may represent a novel diagnostic tool in characterizing gene targets in metastatic cancer. MiRNAs play a number of roles in biological regulation, including development and cell differentiation. When damaged, they can contribute to cancer by either turning on cancer-causing genes or by inhibiting tumor-blocking genes. The ways that MiRNAs are expressed have been used to profile tumor types in humans. Because miRNAs are involved in cancer development and progression, scientists led by Raffaele Baffa, M.D., associate professor of Urology at Jefferson Medical College of Thomas Jefferson University and Anne Rosenberg, M.D., clinical professor of Surgery at Jefferson Medical College, in collaboration with a research team led by Carlo Croce, M.D., director of Ohio State University's human cancer genetics program and professor and chair of the Department of Molecular Virology, Immunology and Medical Genetics, wanted to see if there was a specific gene signature that characterized metastasis. Usingmicroarray technology to test many genes at once, they compared different organs - breast, lung, bladder and colon - to see if miRNAs were either increased or decreased in activity. They analyzed the miRNAs in both primary and metastatic tumors from 43 patients, including 13 breast cancers, 10 lung cancers, 10 bladder urothelial cell cancers and 10 colon cancers.
They discovered that some miRNAs are organ-specific. "Some are increased and decreased specifically in certain organs, telling us that these are commonly involved in the metastatic process," says Dr. Baffa. Because of the ups and downs in miRNA activity, "many miRNAs that are involved in metastasis are not necessarily specific for one organ, but rather are related to the cell acquiring the ability to spread." The researchers also found a direct association between the alterations in some miRNAs and changes in target proteins. Many of the miRNAs that were overexpressed in primary tumors had previously been reported, he says, confirming that miRNA signatures are useful in classifying tissue origin. "Now we have to identify which of the miRNAs in the signature are the most important in facilitating metastasis," Dr. Baffa says. Thomas Jefferson University | |||||||||||||||||||||
|
Related Metastasis News Articles Dense tissue promotes aggressive cancers New research may explain why breast cancer tends to be more aggressive in women with denser breast tissue. Breast cancer cells grown in dense, rigid surroundings step up their invasive activities, Vanderbilt-Ingram Cancer Center investigators report in the Sept. 9 issue of Current Biology. Experiments could lead to new treatments for neuroblastoma Neuroblastoma is one of the most devastating diagnoses a child can receive. The cancer's victims average 2 years old when the disease is detected, most often by a parent feeling a lump in a child's abdomen. By then, the disease has often reached an advanced stage, and advanced neuroblastoma kills more than 50 percent of the children in whom it develops, despite aggressive treatment with surgery, chemotherapy and radiation. Prototype test for predicting clinical outcome for melanoma patients Investigators from the Melbourne Center of the international Ludwig Institute for Cancer Research (LICR) and Pacific Edge Biotchnology Ltd today reported that they have developed a test to predict whether a patient will progress rapidly from Stage III melanoma to metastatic Stage IV cancer and death. Targeted radiation therapy can control limited cancer spread Precisely targeted radiation therapy can eradicate all evidence of disease in selected patients with cancer that has spread to only a few sites, suggests the first published report from an ongoing clinical trial. Discovery of a mechanism that regulates cell movement A study performed by researchers at the Institute for Research in Biomedicine (IRB Barcelona), in collaboration with researchers at the Instituto de Biología Molecular of the CSIC, reveal a mechanism that controls the movement of cells in a tissue by regulating cell adhesion. MDCT, virtual gastroscopy and MPR images differentiate malignant and benign gastric ulcers Multidetector CT using virtual gastroscopy and post contrast enhanced multiplanar reformation images can be useful in differentiating between malignant and benign gastric ulcers, according to a recent study conducted by researchers from Kaohsiung Medical University Hospital in Kaohsiung, Taiwan. Improving understanding of cell behaviour in breast cancer The invasion and spread of cancer cells to other parts of the body, known as metastasis, is a principal cause of death in patients diagnosed with breast cancer. Prostate cancer vaccines more effective with hormone therapy Among patients with castration-resistant prostate cancer, the addition of hormone therapy following vaccine treatment improved overall survival compared with either treatment alone or when the vaccine followed hormone treatment, according to recent data published in the July 15 Clinical Cancer Research, a journal of the American Association for Cancer Research. Idle Computers Offer Hope to Solve Cancer's Mysteries Through Grid Computing Project A biomedical engineering professor at The University of Texas at Austin is using a concept called "grid computing" to allow the average person to donate idle computer time in a global effort to fight cancer. Scientists from the University of Navarra find 5 genes involved in the metastasis of breast tumours to the lung The identification of five genes involve in the metastasis of breast tumours to the lung is the principal finding of a scientific team made up of two bodies from the University of Navarra, the Applied Medical Research Centre (CIMA) and the University Hospital of the University of Navarra. More Metastasis News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||